I don't post here much, but I stumbled across this interesting story:
https://www.redstate.com/brandon_mo...-with-100-survival-rate-into-clinical-trials/
What does this have to do with Crohn's?
How does the treatment work?
According to Pluristem, the PLX cells are “allogeneic mesenchymal-like cells that have immunomodulatory properties.” Translated, that means that they harness our own immune system’s regulatory T cells and M2 macrophages to prevent overactivation of the immune system. This helps us avoid the symptoms of pneumonia and pneumonitis from becoming fatal.
Animal trials have shown that the treatment showed major improvements in regards to “pulmonary hypertension, lung fibrosis, acute kidney injury and gastrointestinal injury,” according to the Post.
https://www.redstate.com/brandon_mo...-with-100-survival-rate-into-clinical-trials/
What does this have to do with Crohn's?
How does the treatment work?
According to Pluristem, the PLX cells are “allogeneic mesenchymal-like cells that have immunomodulatory properties.” Translated, that means that they harness our own immune system’s regulatory T cells and M2 macrophages to prevent overactivation of the immune system. This helps us avoid the symptoms of pneumonia and pneumonitis from becoming fatal.
Animal trials have shown that the treatment showed major improvements in regards to “pulmonary hypertension, lung fibrosis, acute kidney injury and gastrointestinal injury,” according to the Post.
